 Andrew Novick
Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress, Psychological | 9 | 2023 | 975 | 1.690 |
Why?
| | Substance Withdrawal Syndrome | 2 | 2022 | 159 | 1.440 |
Why?
| | Social Behavior | 4 | 2016 | 267 | 1.220 |
Why?
| | Object Attachment | 2 | 2019 | 34 | 1.010 |
Why?
| | Psychiatry | 3 | 2023 | 155 | 0.940 |
Why?
| | Perimenopause | 1 | 2023 | 59 | 0.860 |
Why?
| | Reward | 3 | 2023 | 208 | 0.810 |
Why?
| | Sexual Dysfunctions, Psychological | 1 | 2021 | 31 | 0.770 |
Why?
| | Prefrontal Cortex | 5 | 2015 | 267 | 0.760 |
Why?
| | Midwifery | 1 | 2021 | 47 | 0.740 |
Why?
| | Menopause | 1 | 2023 | 262 | 0.740 |
Why?
| | Estrogen Antagonists | 1 | 2020 | 39 | 0.730 |
Why?
| | Tobacco Use Disorder | 1 | 2022 | 238 | 0.710 |
Why?
| | Dopamine | 5 | 2015 | 237 | 0.710 |
Why?
| | Cognition | 4 | 2023 | 982 | 0.710 |
Why?
| | Dominance-Subordination | 3 | 2015 | 16 | 0.700 |
Why?
| | Tamoxifen | 1 | 2020 | 192 | 0.680 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2020 | 139 | 0.680 |
Why?
| | Asphyxia | 1 | 2019 | 21 | 0.660 |
Why?
| | Panic Disorder | 1 | 2019 | 20 | 0.650 |
Why?
| | Receptors, Opioid, mu | 1 | 2019 | 52 | 0.650 |
Why?
| | Smoking Cessation | 1 | 2022 | 378 | 0.640 |
Why?
| | Citalopram | 1 | 2018 | 27 | 0.630 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2018 | 38 | 0.630 |
Why?
| | Affect | 1 | 2020 | 244 | 0.620 |
Why?
| | Anhedonia | 1 | 2018 | 9 | 0.620 |
Why?
| | Pregnancy Complications | 1 | 2022 | 431 | 0.610 |
Why?
| | Depression | 3 | 2023 | 1149 | 0.610 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2022 | 449 | 0.570 |
Why?
| | Mental Health | 1 | 2022 | 573 | 0.560 |
Why?
| | CA3 Region, Hippocampal | 1 | 2016 | 5 | 0.540 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 40 | 0.500 |
Why?
| | Social Dominance | 2 | 2011 | 17 | 0.480 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 182 | 0.470 |
Why?
| | Space Perception | 1 | 2013 | 62 | 0.440 |
Why?
| | Fear | 1 | 2016 | 296 | 0.440 |
Why?
| | Libido | 2 | 2023 | 24 | 0.420 |
Why?
| | Receptors, Dopamine D1 | 2 | 2011 | 25 | 0.410 |
Why?
| | Mental Disorders | 1 | 2020 | 908 | 0.400 |
Why?
| | Smokers | 2 | 2022 | 147 | 0.400 |
Why?
| | Progesterone | 2 | 2022 | 232 | 0.380 |
Why?
| | Memory, Short-Term | 1 | 2013 | 225 | 0.380 |
Why?
| | Cross-Over Studies | 2 | 2022 | 437 | 0.380 |
Why?
| | Nicotine | 2 | 2022 | 267 | 0.350 |
Why?
| | Antidepressive Agents | 1 | 2011 | 195 | 0.330 |
Why?
| | Safety | 1 | 2011 | 298 | 0.320 |
Why?
| | Humans | 19 | 2023 | 115908 | 0.320 |
Why?
| | Female | 11 | 2023 | 60086 | 0.290 |
Why?
| | Rats, Sprague-Dawley | 5 | 2015 | 2262 | 0.270 |
Why?
| | Pregnancy | 3 | 2022 | 5556 | 0.270 |
Why?
| | Rats | 5 | 2016 | 5035 | 0.250 |
Why?
| | Animals | 11 | 2023 | 32123 | 0.240 |
Why?
| | Premenstrual Dysphoric Disorder | 1 | 2023 | 16 | 0.230 |
Why?
| | Allostasis | 1 | 2023 | 13 | 0.220 |
Why?
| | Pregnanolone | 1 | 2022 | 21 | 0.210 |
Why?
| | Brain | 2 | 2011 | 2382 | 0.210 |
Why?
| | Technology | 1 | 2022 | 77 | 0.200 |
Why?
| | Postmenopause | 1 | 2023 | 301 | 0.200 |
Why?
| | Mood Disorders | 1 | 2022 | 117 | 0.190 |
Why?
| | Contraceptive Agents | 1 | 2022 | 55 | 0.190 |
Why?
| | Disease Models, Animal | 3 | 2016 | 3582 | 0.190 |
Why?
| | Piperazines | 2 | 2015 | 313 | 0.190 |
Why?
| | Biomarkers | 1 | 2011 | 3474 | 0.190 |
Why?
| | Fatigue | 1 | 2022 | 295 | 0.190 |
Why?
| | Taste | 1 | 2023 | 208 | 0.190 |
Why?
| | Mindfulness | 1 | 2022 | 99 | 0.180 |
Why?
| | Adolescent | 3 | 2023 | 17955 | 0.180 |
Why?
| | Contraception | 1 | 2022 | 118 | 0.180 |
Why?
| | Estradiol | 1 | 2023 | 453 | 0.180 |
Why?
| | Cues | 1 | 2022 | 297 | 0.180 |
Why?
| | Benzazepines | 2 | 2011 | 37 | 0.170 |
Why?
| | Anxiety Disorders | 1 | 2022 | 310 | 0.170 |
Why?
| | Nucleus Accumbens | 2 | 2012 | 123 | 0.170 |
Why?
| | Sexual Behavior | 1 | 2023 | 442 | 0.160 |
Why?
| | Fetus | 1 | 2022 | 703 | 0.160 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2017 | 19 | 0.150 |
Why?
| | Mothers | 1 | 2022 | 667 | 0.140 |
Why?
| | Anxiety | 1 | 2022 | 853 | 0.140 |
Why?
| | Tritium | 1 | 2016 | 69 | 0.130 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2016 | 23 | 0.130 |
Why?
| | Dizocilpine Maleate | 1 | 2016 | 15 | 0.130 |
Why?
| | Male | 9 | 2023 | 56128 | 0.130 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2016 | 88 | 0.130 |
Why?
| | Norepinephrine Plasma Membrane Transport Proteins | 1 | 2015 | 5 | 0.130 |
Why?
| | Desipramine | 1 | 2015 | 9 | 0.130 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2015 | 13 | 0.130 |
Why?
| | Smoking | 1 | 2022 | 1468 | 0.130 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2015 | 54 | 0.120 |
Why?
| | Depressive Disorder, Major | 1 | 2017 | 307 | 0.120 |
Why?
| | Mesencephalon | 1 | 2013 | 57 | 0.110 |
Why?
| | Maze Learning | 1 | 2013 | 87 | 0.110 |
Why?
| | Sexual Maturation | 1 | 2013 | 47 | 0.110 |
Why?
| | Child | 3 | 2023 | 18555 | 0.110 |
Why?
| | DNA Methylation | 1 | 2017 | 498 | 0.110 |
Why?
| | Receptors, Dopamine D2 | 1 | 2013 | 86 | 0.110 |
Why?
| | Amphetamine | 1 | 2012 | 22 | 0.110 |
Why?
| | Analysis of Variance | 1 | 2016 | 1226 | 0.110 |
Why?
| | Child Abuse | 1 | 2017 | 455 | 0.110 |
Why?
| | Locomotion | 1 | 2012 | 81 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2022 | 5089 | 0.100 |
Why?
| | Radioligand Assay | 1 | 2011 | 45 | 0.100 |
Why?
| | Bullying | 1 | 2011 | 22 | 0.100 |
Why?
| | Limbic System | 1 | 2011 | 43 | 0.100 |
Why?
| | Maternal Deprivation | 1 | 2011 | 15 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2015 | 1868 | 0.090 |
Why?
| | Protein Binding | 1 | 2016 | 1919 | 0.090 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2017 | 751 | 0.090 |
Why?
| | Age Factors | 2 | 2013 | 2912 | 0.080 |
Why?
| | Rats, Inbred WKY | 1 | 2008 | 32 | 0.080 |
Why?
| | Autoradiography | 1 | 2008 | 71 | 0.080 |
Why?
| | Neostriatum | 1 | 2008 | 29 | 0.080 |
Why?
| | Substantia Nigra | 1 | 2008 | 37 | 0.080 |
Why?
| | Interpersonal Relations | 1 | 2011 | 344 | 0.070 |
Why?
| | Rats, Wistar | 1 | 2008 | 368 | 0.070 |
Why?
| | Species Specificity | 1 | 2008 | 555 | 0.070 |
Why?
| | Amygdala | 1 | 2008 | 179 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2362 | 0.070 |
Why?
| | Young Adult | 1 | 2022 | 10518 | 0.070 |
Why?
| | Adult | 2 | 2022 | 30820 | 0.070 |
Why?
| | Emotions | 1 | 2011 | 486 | 0.070 |
Why?
| | Life Cycle Stages | 1 | 2023 | 31 | 0.060 |
Why?
| | Menstrual Cycle | 1 | 2023 | 110 | 0.050 |
Why?
| | Pituitary-Adrenal System | 1 | 2023 | 162 | 0.050 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2023 | 197 | 0.050 |
Why?
| | Food Preferences | 1 | 2023 | 108 | 0.050 |
Why?
| | Social Class | 1 | 2023 | 213 | 0.050 |
Why?
| | Educational Status | 1 | 2023 | 429 | 0.050 |
Why?
| | Electroencephalography | 1 | 2023 | 366 | 0.050 |
Why?
| | Socioeconomic Factors | 1 | 2023 | 1090 | 0.040 |
Why?
| | Child, Preschool | 2 | 2023 | 9175 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2023 | 2437 | 0.040 |
Why?
| | Gene-Environment Interaction | 1 | 2017 | 194 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2023 | 785 | 0.030 |
Why?
| | Dopamine D2 Receptor Antagonists | 1 | 2013 | 5 | 0.030 |
Why?
| | Sulpiride | 1 | 2013 | 5 | 0.030 |
Why?
| | Quinpirole | 1 | 2013 | 9 | 0.030 |
Why?
| | 3,4-Dihydroxyphenylacetic Acid | 1 | 2013 | 17 | 0.030 |
Why?
| | Microdialysis | 1 | 2013 | 50 | 0.030 |
Why?
| | Dopamine Agonists | 1 | 2013 | 31 | 0.030 |
Why?
| | Catheters, Indwelling | 1 | 2013 | 80 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1129 | 0.030 |
Why?
| | Genotype | 1 | 2017 | 1842 | 0.030 |
Why?
| | Signal Transduction | 1 | 2017 | 4526 | 0.020 |
Why?
|
|
Novick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|